EiRx Therapeutics

company

About

EiRx Therapeutics operates as a research-driven healthcare company developing targeted therapies for the treatment of cancer.

  • 5001 - 10000

Details

Last Funding Type
Seed
Last Funding Money Raised
$180K
Industries
Biotechnology,Health Care
Founded date
Jan 1, 1999
Number Of Employee
5001 - 10000
Operating Status
Active

The Company is based around original concepts and discoveries made by Prof. Tom Cotter (CSO). Tom is a leading international expert in this field and is Professor of Biochemistry at University College Cork.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$180K
EiRx Therapeutics has raised a total of $180K in funding over 2 rounds. Their latest funding was raised on Apr 6, 2005 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2005 Seed $180K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
EiRx Therapeutics is funded by 1 investors. Aurora Private Equity are the most recent investors.
Investor Name Lead Investor Funding Round
Aurora Private Equity Seed